Global Recombinant Protein Purification Service Market Growth (Status and Outlook) 2023-2029

Global Recombinant Protein Purification Service Market Growth (Status and Outlook) 2023-2029

The global Recombinant Protein Purification Service market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Recombinant Protein Purification Service is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Recombinant Protein Purification Service is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Recombinant Protein Purification Service is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Recombinant Protein Purification Service players cover Thermo Fisher Scientific, Abcam, GenScript, ProMab Biotechnologies, Creative Biolabs, Novoprotein, Protein Sciences Corporation, R&D Systems and Bio-Rad Laboratories, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

LPI (LP Information)' newest research report, the “Recombinant Protein Purification Service Industry Forecast” looks at past sales and reviews total world Recombinant Protein Purification Service sales in 2022, providing a comprehensive analysis by region and market sector of projected Recombinant Protein Purification Service sales for 2023 through 2029. With Recombinant Protein Purification Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Recombinant Protein Purification Service industry.

This Insight Report provides a comprehensive analysis of the global Recombinant Protein Purification Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Recombinant Protein Purification Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Recombinant Protein Purification Service market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Recombinant Protein Purification Service and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Recombinant Protein Purification Service.

This report presents a comprehensive overview, market shares, and growth opportunities of Recombinant Protein Purification Service market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Affinity Chromatography
Gel Filtration Chromatography
Ion Exchange Chromatography
Countercurrent Chromatography
Aluminum Hydroxide Affinity Chromatography
Metal Ion Affinity Chromatography
Iodide Affinity Chromatography
Electrophoresis

Segmentation by application
Biopharmaceutical
Medical Diagnosis
Agricultural Science and Technology
Environmental Test
Academic Research

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Thermo Fisher Scientific
Abcam
GenScript
ProMab Biotechnologies
Creative Biolabs
Novoprotein
Protein Sciences Corporation
R&D Systems
Bio-Rad Laboratories
Agilent Technologies
Merck KGaA
AnaSpec
BioLegend
Fitzgerald Industries International
Rockland Immunochemicals
Bethyl Laboratories
EMD Millipore
Expedeon
USBiological
Sigma-Aldrich

Please note: The report will take approximately 2 business days to prepare and deliver.